324 related articles for article (PubMed ID: 10704809)
1. Physical stability and in-vitro gene expression efficiency of nebulised lipid-peptide-DNA complexes.
Birchall JC; Kellaway IW; Gumbleton M
Int J Pharm; 2000 Mar; 197(1-2):221-31. PubMed ID: 10704809
[TBL] [Abstract][Full Text] [Related]
2. Aerosolization of cationic lipid:pDNA complexes--in vitro optimization of nebulizer parameters for human clinical studies.
Eastman SJ; Tousignant JD; Lukason MJ; Chu Q; Cheng SH; Scheule RK
Hum Gene Ther; 1998 Jan; 9(1):43-52. PubMed ID: 9458241
[TBL] [Abstract][Full Text] [Related]
3. Physico-chemical characterisation and transfection efficiency of lipid-based gene delivery complexes.
Birchall JC; Kellaway IW; Mills SN
Int J Pharm; 1999 Jun; 183(2):195-207. PubMed ID: 10361170
[TBL] [Abstract][Full Text] [Related]
4. Non-viral dried powders for respiratory gene delivery prepared by cationic and chitosan loaded liposomes.
Colonna C; Conti B; Genta I; Alpar OH
Int J Pharm; 2008 Nov; 364(1):108-18. PubMed ID: 18775770
[TBL] [Abstract][Full Text] [Related]
5. Characterization of cationic lipid DNA transfection complexes differing in susceptability to serum inhibition.
Nchinda G; Uberla K; Zschörnig O
BMC Biotechnol; 2002 Jul; 2():12. PubMed ID: 12113654
[TBL] [Abstract][Full Text] [Related]
6. [Transfection efficiency comparison of cationic liposome-DNA complexes and lipid-protamine-DNA complexes in vitro].
Sun X; Tian L; Nie Y; Zhang Z; Lu J; Wei Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Feb; 24(1):191-5. PubMed ID: 17333920
[TBL] [Abstract][Full Text] [Related]
7. pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles.
Vighi E; Ruozi B; Montanari M; Battini R; Leo E
Int J Pharm; 2010 Apr; 389(1-2):254-61. PubMed ID: 20100555
[TBL] [Abstract][Full Text] [Related]
8. Nebulisation of IVT mRNA Complexes for Intrapulmonary Administration.
Johler SM; Rejman J; Guan S; Rosenecker J
PLoS One; 2015; 10(9):e0137504. PubMed ID: 26352268
[TBL] [Abstract][Full Text] [Related]
9. Optimization of formulations and conditions for the aerosol delivery of functional cationic lipid:DNA complexes.
Eastman SJ; Tousignant JD; Lukason MJ; Murray H; Siegel CS; Constantino P; Harris DJ; Cheng SH; Scheule RK
Hum Gene Ther; 1997 Feb; 8(3):313-22. PubMed ID: 9048198
[TBL] [Abstract][Full Text] [Related]
10. Examination of the biophysical interaction between plasmid DNA and the polycations, polylysine and polyornithine, as a basis for their differential gene transfection in-vitro.
Ramsay E; Hadgraft J; Birchall J; Gumbleton M
Int J Pharm; 2000 Dec; 210(1-2):97-107. PubMed ID: 11163991
[TBL] [Abstract][Full Text] [Related]
11. The effects of jet nebulisation on cationic liposome-mediated gene transfer in vitro.
Stern M; Sorgi F; Hughes C; Caplen NJ; Browning JE; Middleton PG; Gruenert DC; Farr SJ; Huang L; Geddes DM; Alton EW
Gene Ther; 1998 May; 5(5):583-93. PubMed ID: 9797862
[TBL] [Abstract][Full Text] [Related]
12. Calorimetric study of the interaction of binary DMTAP/DOTAP cationic liposomes with plasmid DNA.
Giatrellis S; Nikolopoulos G; Sideratou Z; Nounesis G
J Liposome Res; 2009; 19(3):220-30. PubMed ID: 19255899
[TBL] [Abstract][Full Text] [Related]
13. A spermine-deoxycholic acid conjugate based lipid as a transfecting agent.
Ajmani PS; Attia S; Osifchin M; Regen S; Hughes JA
Pharmazie; 1999 Mar; 54(3):191-4. PubMed ID: 10192105
[TBL] [Abstract][Full Text] [Related]
14. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes.
Li S; Huang L
Gene Ther; 1997 Sep; 4(9):891-900. PubMed ID: 9349425
[TBL] [Abstract][Full Text] [Related]
15. How does the spacer length of cationic gemini lipids influence the lipoplex formation with plasmid DNA? Physicochemical and biochemical characterizations and their relevance in gene therapy.
Muñoz-Úbeda M; Misra SK; Barrán-Berdón AL; Datta S; Aicart-Ramos C; Castro-Hartmann P; Kondaiah P; Junquera E; Bhattacharya S; Aicart E
Biomacromolecules; 2012 Dec; 13(12):3926-37. PubMed ID: 23130552
[TBL] [Abstract][Full Text] [Related]
16. Viral vector mimicking and nucleus targeted nanoparticles based on dexamethasone polyethylenimine nanoliposomes: Preparation and evaluation of transfection efficiency.
Malaekeh-Nikouei B; Gholami L; Asghari F; Askarian S; Barzegar S; Rezaee M; Kazemi Oskuee R
Colloids Surf B Biointerfaces; 2018 May; 165():252-261. PubMed ID: 29494955
[TBL] [Abstract][Full Text] [Related]
17. Preparation of Lipid-Peptide-DNA (LPD) Nanoparticles and Their Use for Gene Transfection.
Zhang F; Li HY
Methods Mol Biol; 2020; 2118():91-98. PubMed ID: 32152972
[TBL] [Abstract][Full Text] [Related]
18. Nebulised siRNA encapsulated crosslinked chitosan nanoparticles for pulmonary delivery.
Sharma K; Somavarapu S; Colombani A; Govind N; Taylor KM
Int J Pharm; 2013 Oct; 455(1-2):241-7. PubMed ID: 23876499
[TBL] [Abstract][Full Text] [Related]
19. Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin-lipoplexes.
Arangoa MA; Düzgüneş N; Tros de Ilarduya C
Gene Ther; 2003 Jan; 10(1):5-14. PubMed ID: 12525832
[TBL] [Abstract][Full Text] [Related]
20. Nonviral vector for efficient gene transfer to human ovarian adenocarcinoma cells.
Kim CK; Haider KH; Choi SH; Choi EJ; Ahn WS; Kim YB
Gynecol Oncol; 2002 Jan; 84(1):85-93. PubMed ID: 11748982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
